Potential gains in life expectancy from reducing heart disease, cancer, Alzheimer's disease, kidney disease or HIV/AIDS as major causes of death in the USA

Public Health

Volumn 127, Issue 4, 2013, Pages 348-356

  Wang, G D ^a,c   Lai, D J ^a,b   Burau, K D ^a   Du, X L ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b JIANGXI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Alzheimer's disease; Cancer; Heart disease; HIV AIDS; Kidney disease; Life expectancy gains

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE STRUCTURE; CANCER; CARDIOVASCULAR DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; LIFE EXPECTANCY; MENTAL HEALTH; MORTALITY RISK; PUBLIC HEALTH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ALZHEIMER DISEASE; ARTICLE; CAUSE OF DEATH; GENDER; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIFE EXPECTANCY; LIFE TABLE; MORTALITY; NEOPLASM; POTENTIAL GAINS IN LIFE EXPECTANCY; RACE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART DISEASES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

UNITED STATES;

EID: 84876975546     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2013.01.005     Document Type: Article

References (38)

1. Cleries R., Martínez J.M., Valls J., Pareja L., Esteban L., Gispert R., Moreno V., Ribes J., Borràs J.M. Life expectancy and age-period-cohort effects: analysis and projections of mortality in Spain between 1977 and 2016. Public Health 2009, 123:156-162.
2. Kochanek K.D., Xu J., Murphy S.L., Minino A.M., Kung H.C. Deaths: final data for 2009. Natl Vital Stat Rep 2011, 60:1-167.
3. Frieden T.R. A framework for public health action: the health impact pyramid. Am J Public Health 2010, 100:590-595.
4. Arias E. United States life tables, 2007. Natl Vital Stat Rep 2011, 59:1-60.
5. Capewell S., Hayes D.K., Ford E.S., Critchley J.A., Croft J.B., Greenlund K.J., Labarthe D.R. Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. Am J Epidemiol 2009, 170:229-236.
6. Lai D., Tsai S.P., Hardy R.J. Impact of HIV/AIDS on life expectancy in the United States. AIDS 1997, 11:203-207.
7. Lai D.J., Tarwater P.M., Hardy R.J. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000. Public Health 2006, 120:486-492.
8. Lai D., Hardy D.J. An update of impact of HIV/AIDS on life expectancy in the United States. AIDS 2004, 18:1732-1734.
9. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1990, Harvard University Press, Boston. C.J.L. Murray, A.D. Lopez (Eds.).
10. Pamuk E.D., Wagener D.K., Molla M.T. Achieving national health objectives: the impact on life expectancy and on healthy life expectancy. Am J Public Health 2004, 94:378-383.
11. Setel P.W., Saker L., Unwin N.C., Hemed Y., Whiting D.R., Kitange H. Is it time to reassess the categorization of disease burdens in low-income countries?. Am J Public Health 2004, 94:384-388.
12. Chiang C.L. Competing risks in mortality analysis. Ann Rev Public Health 1991, 12:281-307.
13. Lai D., Hardy R.J. Potential gains in life expectancy or years of potential life lost: impact of competing risks of death. Int J Epidemiol 1999, 28:894-898.
14. Chiang C.L. The life table and its applications 1984, Krieger, Malabar, FL.
15. Lai D.J., Lee L.M., Lee E.S. Effects of handicap on life expectancy: the case of China. Public Health 2000, 114:330-335.
16. Lai D., Hardy R.J. Measuring the impact of hepatitis A virus in Chinese cities: a life table approach. Asia Pac J Public Health 2003, 15:94-98.
17. Chiang C.L. Introduction to stochastic processes in biostatistics 1968, Wiley, New York.
18. Tsai S.P., Lee E.S., Hardy R.J. The effects of a reduction in leading causes of death: potential gains in life expectancy. Am J Public Health 1978, 68:966-971.
19. Heron M., Hoyert D.L., Murphy S.L., Xu J., Kochanek K.D., Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 2009, 57:1-134.
20. Bradley C.J., Yabroff K.R., Dahman B., Feuer E.J., Mariotto A., Brown M.L. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst 2008, 100:1763-1770.
21. Coleman M.P., Quaresma M., Berrino F., Lutz J.M., De Angelis R., Capocaccia R., Baili P., Rachet B., Gatta G., Hakulinen T., Micheli A., Sant M., Weir H.K., Elwood J.M., Tsukuma H., Koifman S., E Silva G.A., Francisci S., Santaquilani M., Verdecchia A., Storm H.H., Young J.L. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756. CONCORD Working Group.
22. Yabroff K.R., Bradley C.J., Mariotto A.B., Brown M.L., Feuer E.J. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst 2008, 100:1755-1762.
23. Wong M.D., Ettner S.L., Boscardin W.J., Shapiro M.F. The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy. J Gen Intern Med 2009, 24:475-481.
24. Malone D.C., McLaughlin T.P., Wahl P.M., Leibman C., Arrighi H.M., Cziraky M.J., Mucha L.M. Burden of Alzheimer's disease and association with negative health outcomes. Am J Manag Care 2009, 15:481-488.
25. Mucke L. Neuroscience: Alzheimer's disease. Nature 2009, 461:895-897.
26. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.C. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009, 4(Suppl. 1):5-11.
27. Brosnahan G., Fraer M. Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing. South Med J 2010, 103:140-146.
28. St Peter W.L. Introduction: chronic kidney disease: a burgeoning health epidemic. J Manag Care Pharm 2007, 13(Suppl.):2-5.
29. Fauci A.S. The AIDS epidemic - considerations for the 21st century. N Engl J Med 1999, 341:1046-1050.
30. Bongaarts J., Pelletier F., Gerland P. How many more AIDS deaths?. Lancet 2010, 375:103-104.
31. Walker N., Grassly N.C., Garnett G.P., Stanecki K.A., Ghys P.D. Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic?. Lancet 2004, 363:2180-2185.
32. Kilmarx P.H. Global epidemiology of HIV. Curr Opin HIV AIDS 2009, 4:240-246.
33. El-Sadr W.M., Mayer K.H., Hodder S.L. AIDS in America - forgotten but not gone. N Engl J Med 2010, 362:967-970.
34. Centers for Diseases Control and Prevention: update: mortality attributable to HIV infection among persons aged 25-44 years - United States, 1994. MMWR 1996, 45:121-125.
35. National Center for Health Statistics. Hyattsville: DHHS: National Center for Health Statistics. National Vital Statistics Reports. Available at: 2011 [last accessed 10 February 2012]. http://www.cdc.gov/nchs/.
36. World Health Organization International statistical classification of diseases and related health problems: ICD-10 1992, World Health Organization, Geneva.
37. Miniño A., Murphy S., Xu J., Kochanek K. Deaths: final data for 2008. Natl Vital Stat Rep 2011, 59:1-157.
38. Xu J., Kochanek K., Murphy S., Tejada-Vera B. Deaths: final data for 2007. Natl Vital Stat Rep 2010, 58:1-135.